Scientific Sessions 2025  /  Stroke at the Crossroads: Systemic Links, Shifting Mortality, and Emerging Interventions  /  Use Of Argatroban Plus Antiplatelet Therapy In Patients With Non-Cardioembolic Stroke: A Systematic Review And Meta-Analysis.
Logo

American Heart Association

  96
  0

Final ID: Mo1003

Use Of Argatroban Plus Antiplatelet Therapy In Patients With Non-Cardioembolic Stroke: A Systematic Review And Meta-Analysis.

Abstract Body (Do not enter title and authors here):

The evidence of argatroban and antiplatelet therapy in patients with acute non-cardioembolic stroke ineligible for intravenous thrombolysis or thrombectomy is relatively limited. This meta analysis aimed to evaluate whether argatroban improved efficacy and safety outcomes compared with antiplatelet treatment alone.

A database search was conducted up to April 2025 to identify published trials comparing the use of argatroban plus antiplatelet therapy (experimental group) with antiplatelet therapy alone (control group) in non-cardioembolic stroke. From a total of 186 studies, we included 3 retrospective cohorts and 1 prospective cohort study, encompassing a population of 2,861 patients. The main outcomes assessed included 90-day favorable modified Rankin Scale (mRS) score (0-2), early neurological deterioration (END), change in NIHSS at 7 days, and intracraneal hemorrhage (ICH).

We found that administration of argatroban is associated with a favorable 90-day mRS (RR=1.10, 95%CI: 1.06-1.14, p=<0.00001) and END (RR=0.56 95%CI: 0.32-1.00, P=0.05). No statistically significant difference in change in NIHSS (RR=0.11, 95%CI: -0.50-0.72, P=0.73) and ICH (RR=0.94, 95%CI: 0.56-1.59, P=0.83).

In non-cardioembolic stroke, the use of argatroban in combination with antiplatelet therapy showed better results than antiplatelet therapy alone in terms of functional outcome and prevention of neurological deficit, with no significant increase in intracranial haemorrhage and no change in NIHSS. Further randomised clinical trials are needed to confirm these results.
  • Aragon Cortes, Amiel  ( Universidad Autonoma de Baja California , Tijuana , Baja california , Mexico )
  • Calderon-fernandez, Adolfo  ( Universidad Autonoma de Baja California , Tijuana , Baja california , Mexico )
  • Ramos Pillado, Francisco  ( Universidad Autonoma de Baja California , Tijuana , Baja california , Mexico )
  • Natera, Dilmareth  ( University of Minnesota , Shakopee , Minnesota , United States )
  • García Díaz, Susana Guadalupe  ( Universidad Autonoma del Estado de Mexico , Estado de Mexico , Mexico )
  • Cueva, Luis E.  ( Universidad Nacional de Piura , Piura , Peru )
  • López Mena, Diego  ( Instituto Nacional de Neurologia y Neurocirugia , Ciudad de Mexico , Mexico )
    • Author Disclosures:
    Amiel Aragon Cortes: DO NOT have relevant financial relationships | Adolfo Calderon-Fernandez: DO NOT have relevant financial relationships | Francisco Ramos Pillado: DO NOT have relevant financial relationships | Dilmareth Natera: DO NOT have relevant financial relationships | Susana Guadalupe García Díaz: DO NOT have relevant financial relationships | Luis E. Cueva: DO NOT have relevant financial relationships | Diego López Mena: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Stroke at the Crossroads: Systemic Links, Shifting Mortality, and Emerging Interventions

Monday, 11/10/2025 , 10:30AM - 11:30AM

Abstract Poster Board Session

More abstracts on this topic:
Anticoagulation versus Antiplatelets in Coronary Artery Ectasia and Acute Coronary Syndrome: A Systematic Review and Meta-analysis

Hernandez-pastrana Sarai, Latapi Ruiz Esparza Ximena, Martignoni Felipe, Araiza Diego, Doma Mohamed, Fatima Syeda Rubab, Hemdanieh Maya, Kritya Mangesh, Huang Wilbert, Naji Zahra, Lingamsetty Shanmukh Sai Pavan, Gewehr Douglas

Antithrombotic trends before and after publication of randomized clinical trials in cervical artery dissection: A secondary analysis of the STOP-CAD Study

Penckofer Mary, Salehi Omran Setareh, Seiffge David, Arnold Marcel, Marialuisa Zedde, Zubair Adeel, Marto Joao Pedro, Ghannam Malik, Engelter Stefan, Traenka Christopher, Mac Grory Brian, Shu Liqi, Kam Wayneho, Elnazeir Marwa, Romoli Michele, Saleh Velez Faddi, Siegler James, Strelecky Lukas, Yaghi Shadi, Henninger Nils, Muppa Jayachandra, Bakradze Ekaterina, Heldner Mirjam, Katheryna Antonenko

More abstracts from these authors:
Efficacy And Safety Of Intravenous Thrombolytics For Acute Ischemic Stroke Beyond 4.5 Hours: A Systematic Review And Meta-Analysis.

Yanez Mata Daniela Alejandra, Natera Dilmareth, Cueva Luis E., López Mena Diego, Aragon Cortes Amiel, Velarde Sarabia Damaris, Perez Almaraz Diana, Calderon-fernandez Adolfo, Valenzuela-rangel Alder, Ramos Pillado Francisco, Verber Arano Mario Alberto, Haro Adame Julio Alfredo


Reperfusion Strategies For Medium And Distal Vessel Occlusion: A Systematic Review And Network Meta-Analysis.

Aragon Cortes Amiel, Beltran De La Fuente Andrea Cristina, López Mena Diego, Orozco Santiago Ricardo Alberto, Calderon-fernandez Adolfo, Torrico Beltran Valentina, Cueva Luis E., Natera Dilmareth, Gasca Jose, Zuñiga Montaño Karoly Pamela, Polania Perez Olga Nataly

4359641_File000000.jpg
4359641_File000000.jpg
4359641_File000001.jpg
4359641_File000001.jpg
4359641_File000002.jpg
4359641_File000002.jpg
You have to be authorized to contact abstract author. Please, Login
Not Available